CASR and familial hypocalciuric hypercalcemia: Human CASR mutations are known to be causative for primary hyperparathyroidism (HP) (Bilezikian et al. 2005) and familial benign hypocalciuric hypercalcemia (FHH) (Pollak et al. 1994).